CIBC Private Wealth Group
BCYC

CIBC Private Wealth Group’s Bicycle Therapeutics BCYC Stock Holding History

CIBC Private Wealth Group’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-23
Closed -$160 – 3102
2025
Q2 		$160 Buy
+23
New +$183 ﹤0.01% 2929
2022
Q2 		– Sell
-183
Closed -$8K – 1198
2022
Q1 		$8K Buy
+183
New +$8.55K ﹤0.01% 1155

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

CIBC Private Wealth Group's BCYC Position: Q3 2025 in Review

CIBC Private Wealth Group sold out of Bicycle Therapeutics (BCYC) in Q3 2025, closing a stake of 23 shares — an estimated $160 sold.

CIBC Private Wealth Group first reported a position in BCYC in Q1 2022 and held it in 2 quarters. The position peaked at $8K in Q1 2022. 99 funds tracked by Wall St. Rank hold BCYC as of Q3 2025.

  • CIBC Private Wealth Group reported no remaining Bicycle Therapeutics position as of Q3 2025 after selling out during the quarter.
  • CIBC Private Wealth Group sold 23 Bicycle Therapeutics shares in Q3 2025, an estimated $160.
  • CIBC Private Wealth Group first reported a position in Bicycle Therapeutics in Q1 2022 and held it in 2 quarters.
  • CIBC Private Wealth Group's Bicycle Therapeutics position peaked at $8K in Q1 2022.
  • 99 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2025.

Based on CIBC Private Wealth Group's 13F filing for Q3 2025, filed 24 Nov 2025.